ADMA BIOLOGICS INC (ADMA) Stock Analyst Ratings
NASDAQ:ADMA • US0008991046
15.68 USD
+0.16 (+1.03%)
At close: Feb 25, 2026
16.4 USD
+0.72 (+4.59%)
After Hours: 2/25/2026, 4:19:54 PM
ChartMill assigns a Buy % Consensus number of 82% to ADMA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 26.18. This target is 66.96% above the current price.
- ADMA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ADMA.
- In the previous month the buy percentage consensus was at a similar level.
- ADMA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-03-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-09 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-07-09 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-06-20 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-05-10 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-22 | Mizuho | Maintains | Buy -> Buy |
| 2024-01-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-10 | Mizuho | Maintains | Buy |
| 2022-10-13 | Mizuho | Initiate | Buy |
ADMA BIOLOGICS INC / ADMA FAQ
Can you provide the average price target for ADMA BIOLOGICS INC stock?
9 analysts have analysed ADMA and the average price target is 26.18 USD. This implies a price increase of 66.96% is expected in the next year compared to the current price of 15.68.
What is the consensus rating for ADMA stock?
The consensus rating for ADMA BIOLOGICS INC (ADMA) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.